J&J Marketed Transvaginal Mesh Product For 2 Years Without FDA Approval

How is a medical device on the market for 2 years without the FDA being aware of it?

According to a report from Bloomberg News, Johnson & Johnson’s Gynecare Prolift transvaginal mesh device product was brought to market in 2005, but the U.S. Food & Drug Administration (FDA) was not even aware that the device was being sold until 2007.

According to the report, Johnson & Johnson’s Ethicon unit introduced the Gynecare Prolift transvaginal mesh product, under the assumption that FDA approval was not needed.

The company, the world’s second-biggest health-care products maker, said it could market the original Prolift product without approval because it was so similar to an approved device, the Gynecare Gynemesh.

Upon learning of the Gynecare Prolift’s existence, the FDA informed Johnson & Johnson that it did not agree with the company’s assertion that clearance wasn’t needed for the device. It required Johnson & Johnson to file a 510(k) application for Gynecare Prolift.  The FDA’s 510(k) approval protocols allow a “fast-track” clearance, without a requirement for human testing.

“That information would have been important for most surgeons,” Sokol said. “Most surgeons probably would have not used a completely new product if there was no oversight.”

Johnson & Johnson now faces more than 550 lawsuits filed by women who allege they sustained serious, life-changing injuries following surgery with the Gynecare Prolift vaginal mesh product to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI). The revelation that the device was sold without FDA approval could make those cases far more costly for the company to resolve, Bloomberg said.



,

No comments yet.

Leave a Reply

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Medical Mattresses Pose Risk Of Infection And Contamination

The FDA warns that medical mattresses may not be as clean as once perceived. Routine checks on mattresses are advised as any rips, tears, or excessive wear alter the efficacy. The medical mattresses as well as the covers have an expected life depending on the manufacturer, which should not go unnoticed.

On Third Of Children Medications Are Only Tested On Adults Leading To Improper Use

One third of children medications are not tested on children, but rather adults. Thus, these drugs are approved for adult use. Companies base the dosages off the adult studies, increasing the risk for improper use.

Epilepsy Drug During Pregnancy Linked To Autism

Expectant mothers who take the popular anti-epileptic drug valproate during pregnancy should be aware that there is an increased risk for their child developing autism compared with children of women who did not take the epilepsy drug, according to a recently published Danish study. Valproate is a drug used for the treatment of epilepsy and other [...]

Cough Syrup Responsible For Over 36 Deaths

Pakistani authorities are investigating allegations that cough syrup has killed at least three dozen people, a government official has announced, making this the second time in recent months that medicine is suspected of causing multiple deaths. The deaths from the cough syrup occurred in the eastern city of Gujranwala and nearby villages, said local official [...]

Merck Settles Vioxx Class-Action Lawsuit

In almost a decade old battle, Merck & Co. Inc. has agreed to settle a class action lawsuit filed on behalf of Missouri consumers over its prescription pain reliever Vioxx in a deal that could cost the drugmaker up to $220 million, lawyers for the consumers said. According to CNBC, the agreement announced on November [...]

Latest Medical Device Injury News

Metal-on-Metal Hip Implants Cause Soft Tissue Damage Says FDA

Hip joint deterioration can lead to pain, stiffness or difficulty walking. When these symptoms do not respond to conservative treatment, such as physical therapy, patients may be advised to undergo total hip replacement or hip resurfacing. As part of this treatment, they may receive a “metal-on-metal” hip implant in which the “ball and socket” of [...]

Ethicon Recalls Surgical Stapler

The FDA has announced a voluntary global recall of more than 157,000 Ethicon surgical staplers, due to problems with incomplete firing strokes that may cause faulty staple formation, potentially resulting in painful and severe internal complications for the patient. An Ethicon surgical stapler recall was first announced in August, after reports surfaced where surgeons experienced [...]

Another Device Maker Investigated By DOJ

Earlier this month, cardiovascular device maker Abiomed announced that the US Attorney’s Office was investigating the company’s marketing and labeling of the Impella 2.5 circulatory support device. According to Forbes, the announcement confirmed rumors that had been circulating for at least two weeks, though in the press release the company said it had just been [...]

A Medical Device Horror Story

CNNMoney describes the chilling details of the bone cement horror stories surrounding the medical device company Synthes. In 2009 the U.S. attorney in Philadelphia accused the medical device manufacturer of running illegal clinical trials — essentially, experimenting on humans. Between 2002 and 2004, Synthes tested a product called Norian XR, a cement that has a [...]

Non-FDA Approved Stryker Surgical Device Recall And Alert

Stryker Neptune Waste Management System is the subject of a recent FDA recall and safety alert.  The non-FDA approved device can cause bleeding as well as soft tissue, muscle and vital organ damage. The Stryker Neptune Waste Management System is used during surgical procedures to collect fluid waste from the patient. The Neptune 2 Ultra [...]